Stealth CEO Reenie McCarthy said the FDA made an informed, science-based decision to approve Forzinity, recognizing both the ...
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
The FDA declined to consider elamipretide for full approval in 2021 and rejected the company's application in May of 2025 ...
Medpage Today on MSN
FDA Approves IV Antibiotic for Complicated UTIs
The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
The White House argued lethal military strikes against alleged drug trafficking boats in the Caribbean and Eastern Pacific do ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
MedPage Today on MSN
Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug
T he FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare ...
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...
Ironwood Pharmaceuticals (IRWD) stock gains as the FDA approves a label expansion for the company's AbbVie (ABBV)-partnered ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback